PLAY PODCASTS
Contemporary Management of HIV 2021: First-line ART and Weight Gain—Audio Recap
Episode 57

Contemporary Management of HIV 2021: First-line ART and Weight Gain—Audio Recap

Listen to expert insights from David A. Wohl, MD, on initiating antiretroviral therapy for a treatment-naive patient with HIV, HBV, and obesity.

Decera Clinical Education Infectious Disease Podcast · David A. Wohl MD

June 15, 202116m 48s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, David A. Wohl, MD, discusses current guidelines and clinical trial data informing optimal selection of first-line antiretroviral therapy for HIV.

David A. Wohl, MD    
Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director, HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Link to full program:
https://bit.ly/3ux6FF8


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

operatenofovir dfhiv amberdolutegravirdoravirineabcneuropsychiatric adverse eventsbicral pregnancyias-usa guidelineshbv-hiv coinfectiondtgart weight gaininitial artabacavirhiv treatment-naivedhhs guidelinesbic/ftc/tafantiretroviral therapyhiv weight gainimpaact 2010instistdfdtg/abc/3tcdrv/cobi/ftc/taftsepamohiv geminihiv single-tablet regimensadvanceraldtg ntdsdolutegravir neural tube defectsftc/tdfftc/tafhepatitis b coinfectiondtg/3tcfirst-line artartraltegravir pregnancydolutegravir pregnancyhiv